Mycobacterium haemophilum in immunocompromised patients

Clinical Infectious Diseases

Volumn 33, Issue 3, 2001, Pages 330-337

  Shah, Monika K ^a   Sebti, Abdelghani ^a   Kiehn, Timothy E ^b   Massarella, Susan A ^b   Sepkowitz, Kent A ^a  

^a Infectious Diseases Service   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM HAEMOPHILUM; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES;

EID: 0034920477     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321894     Document Type: Article

References (55)

1. Mycobacterium haemophilum sp. nov., a new pathogen of humans
2. The skin and immunosuppression
3. Unusual mycobacteria in 5 cases of opportunistic infections
4. Mycobacterium haemophilum infections: New York City metropolitan area, 1990-1991
5. Mycobacterium haemophilum: A new opportunistic pathogen
6. A cluster of four cases of Mycobacterium haemophilum infection
7. Mycobacterium haemophilum: An emerging pathogen
8. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients
9. Mycobacterium haemophilum: Microbiology and expanding geographic spectra of disease in humans
10. Mycobacterium haemophilum infections in bone marrow transplant recipients
11. Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host
12. Histologic reactions to cutaneous infections by Mycobacterium haemophilum
13. Osteomyelitis caused by Mycobacterium haemophilum: Ssuccessful therapy in two patients with AIDS
14. Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome
15. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome
16. Two cases of Mycobacterium haemophilum infection in Canada
17. Mycobacterium haemophilum infection in a patient with AIDS
18. Mycobacterium haemophilum infection in immunocompromised patients: Case report and review of the literature
19. Infection with Mycobacterium haemophilum
20. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS
21. Mycobacterium haemophilum osteomyelitis in an AIDS patient
22. Osteomyelitis due to Mycobacterium haemophilum in a patient with AIDS
23. Successful treatment of disseminated Mycobacterium haemophilum infection in a patient with AIDS
24. Mycobacterium haemophilum skin disease successfully treated with excision
25. Mycobacterium haemophilum infection in AIDS
26. Mycobacterium haemophilum infection in a patient with AIDS
27. Considering Mycobacterium haemophilum in the differential diagnosis for lytic bone lesions in AIDS patients who present with ulcerating skin lesions
28. Recrudescence of cutaneous Mycobacterium haemophilum lesions following tetanus immunization
29. Skin lesions caused by Mycobacterium haemophilum
30. Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus
31. New characteristics of Mycobacterium haemophilum
32. Mycobacterium haemophilum and Myeobacterium xenopi associated infection in a renal transplant patient
33. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit
34. Infectious complications after heart transplantation
35. Mycobacterium haemophilum cellulitis in a heart transplant recipient
36. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: Case report and analysis of interactions among clarithromycin, rifampin and cyclosporine
37. Mycobacterial central venous catheter tunnel infection: A difficult clinical problem
38. Pyomyositis due to Mycobacterium haemophilum in a patient with polymyositis and long-term steroid use
39. Mycobacterium haemophilum infection in an elderly patient
40. Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child
41. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children
42. Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy
43. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections
44. Further studies of a new pathogenic mycobacterium (M. haemophilum sp. nov.)
45. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum
46. Evaluation of a simple method for growing Mycobacterium haemophilum
47. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum
48. Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum
49. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice
50. Effect of HAART on natural history of AIDS-related opportunistic disorders
51. Focal mycobacterial lymphadenitis following initiation of protease inhibitor therapy in patients with advanced HIV-1 disease
52. Mycobacterial skin infection by an unidentified species: A report of 29 patients
53. Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin
54. Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin
55. DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis